Pieris Pharmaceuticals GmbH

A Focused Approach to Therapeutics

At Pieris, we combine leading protein engineering capabilities and deep insights into molecular drivers of disease to develop medicines that drive local biology to produce superior clinical outcomes for patients. Our proprietary Anticalin® technology based on human lipocalins – proteins that naturally bind and transport molecules throughout the body – forms the basis of our development focus to effect a local mechanism of action to address cancer and respiratory diseases. Our biologics have been validated in the clinic and by partnerships with leading pharmaceutical companies.